70 related articles for article (PubMed ID: 7587951)
1. Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909.
de Groot MJ; Bijloo GJ; Hansen KT; Vermeulen NP
Drug Metab Dispos; 1995 Jun; 23(6):667-9. PubMed ID: 7587951
[No Abstract] [Full Text] [Related]
2. Involvement of CYP2D6 in oxidative metabolism of cinnarizine and flunarizine in human liver microsomes.
Narimatsu S; Kariya S; Isozaki S; Ohmori S; Kitada M; Hosokawa S; Masubuchi Y; Suzuki T
Biochem Biophys Res Commun; 1993 Jun; 193(3):1262-8. PubMed ID: 8323546
[TBL] [Abstract][Full Text] [Related]
3. [Cytochrome P-450-dependent monooxygenases and their relation to bioluminescence and biochemiluminescence].
Danilov VS
Dokl Akad Nauk SSSR; 1987; 294(6):1477-80. PubMed ID: 3622230
[No Abstract] [Full Text] [Related]
4. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
[TBL] [Abstract][Full Text] [Related]
5. [Biotransformation of sparteine in the Cuna American Indians of Panama].
Arias TD; Jorge L; Lee D; Guerrero de Solís N; Escobar J; Barrantes R; Inaba T
Rev Med Panama; 1986 Sep; 11(3):199-209. PubMed ID: 3468564
[No Abstract] [Full Text] [Related]
6. Clinically significant cytochrome P-450 drug interactions--a comment.
Ford NF; Sonnichsen DS
Pharmacotherapy; 1998; 18(4):890-1; discussion 892-3. PubMed ID: 9692671
[No Abstract] [Full Text] [Related]
7. Aromatic ring oxidation of N-n-butylamphetamine is enhanced in the rat by prior treatment with quinidine.
Coutts RT; Baker GB; Malek F; Hussain MS
Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):15-24. PubMed ID: 1801101
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of trimipramine in vitro by human CYP2D6 isozyme.
Bolaji OO; Coutts RT; Baker GB
Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):111-20. PubMed ID: 8272570
[TBL] [Abstract][Full Text] [Related]
10. Bladder cancer recurrence and its association with cytochrome P-450IID6 activity.
Persad RA; Fleming CM; Wilkinson GR; Smith PJ; Branch RA
Prog Clin Biol Res; 1992; 378():19-27. PubMed ID: 1301581
[No Abstract] [Full Text] [Related]
11. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
Ebner T; Meese CO; Eichelbaum M
Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of low molecular weight chloroalkanes by cytochrome P450CAM.
Lefever MR; Wackett LP
Biochem Biophys Res Commun; 1994 May; 201(1):373-8. PubMed ID: 8198597
[TBL] [Abstract][Full Text] [Related]
13. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.
Landi MT; Ceroni M; Martignoni E; Bertazzi PA; Caporaso NE; Nappi G
Adv Neurol; 1996; 69():61-72. PubMed ID: 8615186
[No Abstract] [Full Text] [Related]
14. Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6.
Mautz DS; Nelson WL; Shen DD
Drug Metab Dispos; 1995 Apr; 23(4):513-7. PubMed ID: 7600921
[TBL] [Abstract][Full Text] [Related]
15. [Cytochrome p450 IID6, its role in psychopharmacology].
Lamard L; Pérault MC; Bouquet S; Guibert S
Ann Med Psychol (Paris); 1995 Feb; 153(2):140-3. PubMed ID: 7741408
[TBL] [Abstract][Full Text] [Related]
16. Protein oxidation by the cytochrome P450 mixed-function oxidation system.
Stadtman ER; Arai H; Berlett BS
Biochem Biophys Res Commun; 2005 Dec; 338(1):432-6. PubMed ID: 16140263
[TBL] [Abstract][Full Text] [Related]
17. [Oxidation of organic compounds by Rhodococcus erythropolis 3/89 propanomonooxygenase].
Kulikova AK; Bezborodov AM
Prikl Biokhim Mikrobiol; 2000; 36(3):267-71. PubMed ID: 10867943
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced hepatotoxicity.
Fenichel RR
N Engl J Med; 1996 Mar; 334(13):864. PubMed ID: 8596562
[No Abstract] [Full Text] [Related]
19. Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.
Broly F; Meyer UA
Pharmacogenetics; 1993 Jun; 3(3):123-30. PubMed ID: 8101460
[TBL] [Abstract][Full Text] [Related]
20. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
